Related Experiment Video
Updated: Aug 13, 2026

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Mouse Models of Human Cancers Consortium Workshop on Nervous System Tumors
David H Gutmann1, Elizabeth A Maher, Terry Van Dyke
1Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA. gutmannd@neuro.wustl.edu
Abstract:
Nervous system tumors are clinically challenging neoplasms that form within the central and peripheral nervous system. Although there have been many clinical trials using novel agents for the treatment of primary brain tumors, there have been few advances that positively affect overall patient survival. Over the past several years, there has been significant progress in the development of accurate small-animal spontaneous brain tumor models, small-animal neuroimaging, and tools for the bioinformatic analysis of complex molecular data sets, all of which have contributed to an improved understanding of the pathogenesis of human brain tumors. Whereas these models will continue to be of great value in basic science investigations, they can also be used to identify and validate potential therapies for brain tumors and to evaluate these drugs in preclinical trials. The National Cancer Institute recently convened a workshop to review the current state of small-animal brain tumor modeling and to make recommendations about the use of these models to improve the clinical outcome for patients with brain tumors. In this meeting report, we outline the current state of small-animal models for brain tumors, the potential applications of these models, and the recommendations made by the workshop participants for the use of mouse models in the preclinical evaluation of potential brain tumor therapies.
Insights
Small-animal brain tumor models are advancing our understanding of nervous system tumors. These models are crucial for identifying and testing new therapies to improve patient survival in clinical trials.
Area of Science:
- Neuro-oncology
- Translational Cancer Research
Background:
- Nervous system tumors, including primary brain tumors, present significant clinical challenges with limited improvements in patient survival.
- Despite numerous clinical trials, effective treatments for brain tumors remain elusive.
Framework:
- Advancements in small-animal spontaneous brain tumor models, neuroimaging, and bioinformatics have enhanced understanding of human brain tumor pathogenesis.
- These sophisticated models are pivotal for basic science research and the identification of novel therapeutic targets.
Implementation:
- Small-animal models are instrumental in validating potential brain tumor therapies.
- These models facilitate the rigorous evaluation of drug efficacy in preclinical settings.
Implications:
- The National Cancer Institute convened a workshop to assess current small-animal brain tumor models and their clinical application.
- Recommendations focus on optimizing the use of mouse models for preclinical evaluation to improve clinical outcomes for brain tumor patients.
More Related Videos
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

